Chris Fuglesang

Dr. Fuglesang joined Tavistock Life Sciences in 2005. He has responsibilities for portfolio intellectual property, the management of existing portfolio companies, and the identification of prospective public and private investments. Prior to joining Tavistock, Dr. Fuglesang was Vice President at Eidogen, a structural proteomics software company, and a practicing attorney at Perkins Coie LLC in their biotechnology practice group. Dr. Fuglesang received a B.S. in both Chemistry and Physics from the University of California at Los Angeles, a Ph.D. in Theoretical Chemical Physics from the University of California at Los Angeles, and a J.D. from Boston University.